This inventor holds 7 USPTO granted patents, plus 8 CIPO patents and 2 EPO patents. Top assignees: Bayer Aktiengesellschaft, Actimis Pharmaceuticals, Inc., Bayer Healthcare Aktiengesellschaft. Active years: 2003-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nara, JP (2003)
- Nara-ken, JP (2006 - 2011)
Company Filing History:
4 out of 12,269 
2 out of 8 
1 out of 77 Years Active: 2003-2011
Title: Hiroki Sato: Innovator in Pharmaceutical Chemistry
Introduction
Hiroki Sato is a prominent inventor based in Nara-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of pyrimidine derivatives. With a total of 7 patents to his name, Sato's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Sato's latest patents focuses on pyrimidine derivatives that are useful for the treatment of diseases mediated by CRTH2. This invention relates to a pyrimidine derivative of a specific formula and its salts, which serve as active ingredients in pharmaceutical preparations. The derivative exhibits excellent antagonistic activity against CRTH2, a G-protein-coupled chemoattractant receptor expressed on Th2 cells. It can be utilized for the prophylaxis and treatment of diseases associated with CRTH2 activity, including allergic diseases such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis. Additionally, it addresses eosinophil-related diseases like Churg-Strauss syndrome and sinusitis, as well as basophil-related diseases such as basophilic leukemia and chronic urticaria. Furthermore, it has applications in treating inflammatory diseases characterized by T lymphocytes and extensive leukocyte infiltrates, including psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, chronic obstructive pulmonary disorder (COPD), and arthritis.
Career Highlights
Throughout his career, Hiroki Sato has worked with notable companies, including Bayer Aktiengesellschaft and Actimis Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Sato has collaborated with esteemed colleagues, including Yuji Koriyama and Takuya Shintani. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Hiroki Sato's innovative work in the development of pyrimidine derivatives showcases his commitment to advancing pharmaceutical science. His contributions have the potential to improve treatment options for various diseases, making him a significant figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile